- Report
- March 2024
- 181 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 89 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- January 2024
- 150 Pages
Global
From €4681EUR$4,850USD£4,016GBP
- Report
- November 2023
- 167 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- October 2023
- 165 Pages
United States
From €2413EUR$2,500USD£2,070GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- August 2023
- 150 Pages
Global
From €4102EUR$4,250USD£3,519GBP
- Report
- February 2024
- 305 Pages
Global
From €3507EUR$3,633USD£3,008GBP
€5009EUR$5,190USD£4,297GBP
- Report
- December 2019
- 240 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- February 2019
- 110 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- August 2022
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2022
- 40 Pages
India
From €2505EUR$2,595USD£2,149GBP
- Report
- March 2020
- 100 Pages
Global
From €4628EUR$4,795USD£3,970GBP
- Report
- January 2022
- 40 Pages
Russia
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2022
- 40 Pages
South Korea
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2022
- 40 Pages
United States
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €2505EUR$2,595USD£2,149GBP
- Report
- January 2022
- 80 Pages
Africa
From €3663EUR$3,795USD£3,142GBP
- Report
- January 2022
- 40 Pages
Brazil
From €2505EUR$2,595USD£2,149GBP
The Neurodiagnostics market is a subset of the Diagnostics industry, focusing on the diagnosis and treatment of neurological disorders. It includes a range of technologies and services, such as imaging, EEG, EMG, and evoked potentials, to diagnose and monitor neurological conditions. Neurodiagnostics also includes the use of biomarkers to detect and monitor neurological diseases.
The Neurodiagnostics market is driven by the increasing prevalence of neurological disorders, the development of new technologies, and the growing demand for personalized medicine. Additionally, the increasing focus on preventive healthcare and the rising awareness of neurological disorders are expected to drive the market.
Some companies in the Neurodiagnostics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Medtronic, and Natus Medical. Show Less Read more